Lupus Erythematosus Cutaneous
📧 Sign up to get email alerts when something new happens for Lupus Erythematosus Cutaneous.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. [Phase 2]
Phase 2 clinical trial evaluating PF-06823859 in adults with active cutaneous and systemic lupus erythematosus; study terminated with result…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Duke University’s MADRA pregnancy autoimmune disease registry is actively recruiting to study autoimmune conditions during pregnancy, includ…
-
CLINICAL_TRIALS withdrawal · 2024-12-06Clinical Trial Update: Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars [NA]
A clinical trial evaluating the efficacy of fractional Er:YAG laser for lupus erythematosus cutaneous scars has been withdrawn from the regi…
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Autologous Polyclonal Tregs for Lupus [Phase 1]
Phase 1 trial update of autologous polyclonal T regulatory cells for lupus; study terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus [Phase 2]
Phase 2 trial evaluating intradermal etanercept for remission induction in discoid lupus erythematosus has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.